FDA advances peptide push to White House
The Hill · C · trust 67/100
Presented by Coalition to Strengthen America’s Healthcare {beacon} Healthcare Healthcare The Big Story RFK Jr. advances peptide push The Food and Drug Administration (FDA) this week submitted a peptide “interim access policy” to the White House for review, according to a government filing, which would reportedly allow compounding pharmacies to temporarily produce and sell previously restricted...
Read the original at The Hill →
Open in TruthVane →